Elanco Animal Health Incorporated (ELAN) Financials

ELAN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 13.6 billion 7.0 billion
March 31, 2026 13.2 billion 6.7 billion
Dec. 31, 2025 13.4 billion 6.8 billion
Sept. 30, 2025 13.6 billion 6.8 billion

ELAN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 244.0 million 20.0 million
March 31, 2026 -38.0 million 21.0 million
Dec. 31, 2025 46.0 million 16.0 million
Sept. 30, 2025 127.0 million 17.0 million

ELAN Net Income

No data available :(

ELAN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 530.0 million 3.8 billion -
March 31, 2026 428.0 million 3.9 billion -
Dec. 31, 2025 545.0 million 3.9 billion -
Sept. 30, 2025 505.0 million 4.0 billion -

ELAN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 505.9 million
March 31, 2026 506.0 million
Dec. 31, 2025 496.9 million
Sept. 30, 2025 496.8 million

ELAN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 33.0 million 92.0 million 449.0 million 449.0 million
March 31, 2026 51.0 million 97.0 million 381.0 million -
Dec. 31, 2025 62.0 million 93.0 million 338.0 million -
Sept. 30, 2025 92.0 million 89.0 million 351.0 million -

ELAN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.4 billion 570.0 million
March 31, 2026 1.4 billion 586.0 million
Dec. 31, 2025 1.1 billion 694.0 million
Sept. 30, 2025 1.1 billion 530.0 million

ELAN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ELAN

Price: $22.41

52 week price:
19.40
27.98

Earnings Per Share: -0.41 USD

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 5.1 million

Market Capitalization: 11.1 billion

Links: